Search Results 411-420 of 1117 for SCA
The purpose of this study is to evaluate JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway ...
In 2012, the US Food and Drug Administration approved the first subcutaneous implantable cardioverter-defibrillator (S-ICD) system for use.
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
The purpose of this study is to collect medical and personal histories, blood and/or tumor tissue samples from patients who are long-term survivors of lung ...
Dr. Gregory Poland 00:03. The FDA approved a new booster formulation. So, it's part the previous booster that we got and part a combination of BA.4 and 5.
The purpose of this study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14- ...
To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...
About this study. RATIONALE: Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.
Mayo Clinic researchers are working to improve diagnosis and treatment of subarachnoid hemorrhages. Specific efforts include improved imaging of bleeding and ...
An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR ( ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.